Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Jul 25, 2017, 08:45 ET Biotech Sector Continued Resurgence Fueled by Increasing Clinical Trial Activity & Business Friendly FDA Leadership

The rising stability provided by business friendly leadership at the top of the Federal Food & Drug Administration these days has created a...


Jul 25, 2017, 08:30 ET Potential Blockbuster Treatment for Alzheimer's Disease Stands Out Among Medical Cannabis Companies

Changes in public opinion regarding cannabis have greatly fueled the fire blazing under the red-hot state-legalized marijuana market. A recent...


Jul 25, 2017, 08:30 ET Regulus to Provide Second Quarter 2017 Financial Results on August 1, 2017

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...


Jul 25, 2017, 08:30 ET Sensus Healthcare to Host Second Quarter 2017 Financial Results and Business Update Conference Call on August 3, 2017

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and...


Jul 25, 2017, 08:03 ET ICYMI: TechCrunch Features Restore™ Soft Suit Showcase at MIT's MassRobotics Event

An in-depth story in TechCrunch covers the recent public debut of Restore, the new soft suit exoskeleton created in collaboration by ReWalk...


Jul 25, 2017, 08:00 ET SOM Biotech Licenses its First Product and Expands to the United States

The med-tech biopharmaceutical company SOM Biotech, specializing in repurposing drugs to treat rare nervous system diseases, has concluded a...


Jul 25, 2017, 08:00 ET Regen BioPharma, Inc. Research Demonstrates Ex-Vivo Immune Suppression With Novel NR2F6 Activators

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) today reported continued progress in Regen's development of small molecule drugs that...


Jul 25, 2017, 08:00 ET HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema

Global biotherapeutics leader CSL Behring announced today that HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) is now available in...


Jul 25, 2017, 08:00 ET Kezar Life Sciences Announces Successful Completion of Phase 1a Study and Secures $50 Million in Series B Financing

Kezar Life Sciences, a private, clinical-stage biopharmaceutical company developing novel small molecule therapeutics targeting the...


Jul 25, 2017, 08:00 ET Spherix Announces the Formation of a Technology Advisory Board in Area of BioPharmaceutical Opportunities

Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to the fostering of...


Jul 25, 2017, 08:00 ET Josh Schimmer Joins Evercore ISI Research Team

Evercore (NYSE: EVR) announced today that Josh Schimmer has joined the Evercore ISI Healthcare Research team, as a Senior Managing Director,...


Jul 25, 2017, 08:00 ET Trovagene Announces Peer-Reviewed Publication of First-in-Human Phase 1 Trial Results with PCM-075, its Polo-like Kinase 1 (PLK1) Inhibitor

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced the publication of clinical results from a Phase 1 dose...


Jul 25, 2017, 07:50 ET Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody

Frontier Biotechnologies, Inc., a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products...


Jul 25, 2017, 07:30 ET Rigel Announces Conference Call and Webcast to Report Second Quarter 2017 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its second quarter financial results after market close on Tuesday,...


Jul 25, 2017, 07:30 ET Bioengineered Protein Drugs Market Worth US$336.9 Billion by 2025: Increasing Drugs in Phase III of Clinical Trials to Boost the Market

Some of the prominent participants in the global bioengineered protein drugs market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Amgen,...


Jul 25, 2017, 07:12 ET AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B

AzarGen Biotechnologies (Pty) Ltd (Stellenbosch, South Africa), announced that it has received grant status for the patent application:...


Jul 25, 2017, 07:10 ET Stock Performance Review on Biotech Industry -- BioPharmX, AmpliPhi Biosciences, Actinium Pharma, and Matinas BioPharma

If you want a Stock Review on BPMX, APHB, ATNM, or MTNB then come over to http://dailystocktracker.com/register/ and sign up for your free...


Jul 25, 2017, 07:00 ET EnteroMedics Announces First Veterans Choice Program vBloc® Implant for Obesity at Methodist Dallas Medical Center

EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity, metabolic diseases and other...


Jul 25, 2017, 07:00 ET BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today...


Jul 25, 2017, 07:00 ET OWC Pharmaceutical Research Corp Appoints Dr. Stanley Hirsch as its Active Chairman

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), a developer of cannabinoid-based therapies targeting a variety of...